Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology

Nagarajan, 2019, Keratinocyte carcinomas: current concepts and future research priorities, Clin Cancer Res, 25, 2379, 10.1158/1078-0432.CCR-18-1122 Aggarwal, 2021, United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019, J Am Acad Dermatol, 85, 388, 10.1016/j.jaad.2021.03.109 Lo, 1991, Metastatic basal cell carcinoma: report of twelve cases with a review of the literature, J Am Acad Dermatol, 24, 715, 10.1016/0190-9622(91)70108-E Alam, 2018, Guidelines of care for the management of cutaneous squamous cell carcinoma, J Am Acad Dermatol, 78, 560, 10.1016/j.jaad.2017.10.007 McCusker, 2014, Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease, Eur J Cancer, 50, 774, 10.1016/j.ejca.2013.12.013 Schunemann Alonso-Coello, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines, Br Med J, 353, i2089, 10.1136/bmj.i2089 Brouwers, 2016, The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines, Br Med J, 352, i1152, 10.1136/bmj.i1152 Olsen, 2015, Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use, Aust N Z J Public Health, 39, 471, 10.1111/1753-6405.12470 Diepgen, 2012, Occupational skin cancer induced by ultraviolet radiation and its prevention, Br J Dermatol, 167, 76, 10.1111/j.1365-2133.2012.11090.x Loney, 2021, Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review, Br J Dermatol, 184, 208, 10.1111/bjd.19152 Corona, 2001, Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life, Arch Dermatol, 137, 1162, 10.1001/archderm.137.9.1162 Karagas, 2014, Early-onset basal cell carcinoma and indoor tanning: a population-based study, Pediatrics, 134, e4, 10.1542/peds.2013-3559 Zhang, 2012, Use of tanning beds and incidence of skin cancer, J Clin Oncol, 30, 1588, 10.1200/JCO.2011.39.3652 Burnett, 2011, Current sunscreen controversies: a critical review, Photodermatol Photoimmunol Photomed, 27, 58, 10.1111/j.1600-0781.2011.00557.x Farmer, 1996, Sun exposure, sunscreens, and skin cancer prevention: a year-round concern, Ann Pharmacother, 30, 662, 10.1177/106002809603000615 Lin, 2011, Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force, Ann Intern Med, 154, 190, 10.7326/0003-4819-154-3-201102010-00009 Sánchez, 2016, Sun protection for preventing basal cell and squamous cell skin cancers, Cochrane Database Syst Rev, 7, CD011161 Green, 1999, Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial, Lancet, 354, 723, 10.1016/S0140-6736(98)12168-2 Pandeya, 2005, Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial, Am J Epidemiol, 161, 748, 10.1093/aje/kwi098 Apalla, 2014, Applicability of dermoscopy for evaluation of patients’ response to nonablative therapies for the treatment of superficial basal cell carcinoma, Br J Dermatol, 170, 809, 10.1111/bjd.12749 Lallas, 2014, Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma, J Am Acad Dermatol, 70, 303, 10.1016/j.jaad.2013.10.003 Kittler, 2016, Standardization of terminology in dermoscopy/dermatoscopy: results of the third consensus conference of the International Society of Dermoscopy, J Am Acad Dermatol, 74, 1093, 10.1016/j.jaad.2015.12.038 Argenziano, 2006, Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer, J Clin Oncol, 24, 1877, 10.1200/JCO.2005.05.0864 Alarcon, 2014, Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions, Br J Dermatol, 170, 802, 10.1111/bjd.12678 Pellacani, 2014, Reflectance confocal microscopy as a second-level examination in skin oncology improves diagnostic accuracy and saves unnecessary excisions: a longitudinal prospective study, Br J Dermatol, 171, 1044, 10.1111/bjd.13148 Nelson, 2016, Accuracy and confidence in the clinical diagnosis of basal cell cancer using dermoscopy and reflex confocal microscopy, Int J Dermatol, 55, 1351, 10.1111/ijd.13361 Witkowski, 2016, Non-invasive diagnosis of pink basal cell carcinoma: how much can we rely on dermoscopy and reflectance confocal microscopy?, Skin Res Technol, 22, 230, 10.1111/srt.12254 Bath-Hextall, 2004, Interventions for basal cell carcinoma of the skin: systematic review, BMJ, 329, 10.1136/bmj.38219.515266.AE Thomson, 2020, Interventions for basal cell carcinoma of the skin, Cochrane Database Syst Rev, 11, CD003412 Silverman, 1991, Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation, J Dermatol Surg Oncol, 17, 720, 10.1111/j.1524-4725.1991.tb03425.x Zane, 2017, Pulsed CO2 laser ablation of superficial basal cell of limbs and trunk: a comparative randomized clinical trial with cryotherapy and surgical ablation, Dermatol Surg, 43, 920, 10.1097/DSS.0000000000001106 Arits, 2013, Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial, Lancet Oncol, 14, 647, 10.1016/S1470-2045(13)70143-8 Butler, 2009, Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study, Dermatol Surg, 35, 24 Kalka, 2000, Photodynamic therapy in dermatology, J Am Acad Dermatol, 42, 389, 10.1016/S0190-9622(00)90209-3 Roozeboom, 2016, Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial, J Invest Dermatol, 136, 1568, 10.1016/j.jid.2016.03.043 Pennington, 2005, Mohs micrographic surgery: established uses and emerging trends, Oncology (Williston Park), 19, 1165 Rowe, 1989, Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma, J Dermatol Surg Oncol, 15, 424, 10.1111/j.1524-4725.1989.tb03249.x Malhotra, 2004, The Australian Mohs database, part II: Periocular basal cell carcinoma outcome at 5-year follow-up, Ophthalmology, 111, 631, 10.1016/j.ophtha.2003.11.004 Leibovitch, 2005, Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up, J Am Acad Dermatol, 53, 452, 10.1016/j.jaad.2005.04.087 Bertino, 2016, European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer, Eur J Cancer, 63, 41, 10.1016/j.ejca.2016.05.001 Campana, 2017, Basal cell carcinoma: 10-year experience with electrochemotherapy, J Transl Med, 15, 122, 10.1186/s12967-017-1225-5 Clover, 2020, Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up, Eur J Surg Oncol, 46, 847, 10.1016/j.ejso.2019.11.509 Gulleth, 2010, What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature, Plast Reconstr Surg, 126, 1222, 10.1097/PRS.0b013e3181ea450d van Loo, 2014, Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up, Eur J Cancer, 50, 3011, 10.1016/j.ejca.2014.08.018 Mosterd, 2008, Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up, Lancet Oncol, 9, 1149, 10.1016/S1470-2045(08)70260-2 Smeets, 2004, Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial, Lancet, 364, 1766, 10.1016/S0140-6736(04)17399-6 Colombo, 2008, Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors, Ther Clin Risk Manag, 4, 541, 10.2147/TCRM.S2780 Kis, 2019, Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas, Sci Rep, 9, 4285, 10.1038/s41598-019-41026-2 Ozolins, 2010, Bath-Hextall FJ. The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma, Trials, 11, 42, 10.1186/1745-6215-11-42 Bath-Hextall, 2014, Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial, Lancet Oncol, 15, 96, 10.1016/S1470-2045(13)70530-8 Williams, 2017, Surgery versus imiquimod for nodular and superficial basal cell carcinoma (SINS) study group. Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the sins randomized controlled trial, J Invest Dermatol, 137, 614, 10.1016/j.jid.2016.10.019 Wang, 2015, Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis, Photodermatol Photoimmunol Photomed, 31, 44, 10.1111/phpp.12148 Zou, 2016, Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis, J Cosmet Dermatol, 15, 374, 10.1111/jocd.12236 Thissen, 2000, Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck, Dermatol Surg, 26, 759, 10.1046/j.1524-4725.2000.ds00064.x Caccialanza, 2009, Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: our experience in 671 lesions, J Eur Acad Dermatol Venereol, 23, 1044, 10.1111/j.1468-3083.2009.03247.x Russi, 2015, Facial basal cell carcinomas in elderly frail patients treated with low total-dose radiotherapy, Anticancer Res, 35, 4949 Pelissero, 2015, Facial basal cell carcinomas treated with hypo-fractionated radiotherapy: a retrospective analysis in 117 elderly patients, J Am Acad Dermatol, 73, 166, 10.1016/j.jaad.2015.03.030 Voss, 1998, Radiotherapy in the treatment of dermatologic malignancies, Dermatol Clin, 16, 313, 10.1016/S0733-8635(05)70013-9 Finizio, 2002, What is the current role of radiation therapy in the treatment of skin carcinomas?, Tumori, 88, 48 Cognetta, 2012, Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients, J Am Acad Dermatol, 67, 1235, 10.1016/j.jaad.2012.06.001 Schulte, 2005, Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas, J Am Acad Dermatol, 53, 993, 10.1016/j.jaad.2005.07.045 Jackson, 2009, Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach, Head Neck, 31, 604, 10.1002/hed.20991 Rio, 2005, Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases, Int J Radiat Oncol Biol Phys, 63, 753, 10.1016/j.ijrobp.2005.03.027 Krengli, 2014, Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients, Strahlenther Onkol, 190, 245, 10.1007/s00066-013-0495-y 2016 Avril, 1997, Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study, Br J Cancer, 76, 100, 10.1038/bjc.1997.343 Wilson, 2004, Surgical management of incompletely excised basal cell carcinomas of the head and neck, Br J Oral Maxillofac Surg, 42, 311, 10.1016/j.bjoms.2004.02.030 Liu, 1991, A management approach to incompletely excised basal cell carcinomas of skin, Int J Radiat Oncol Biol Phys, 20, 423, 10.1016/0360-3016(91)90052-6 Peris, 2015, Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus, Future Oncol, 11, 703, 10.2217/fon.14.281 Zoccali, 2012, Giant basal cell carcinoma of the skin: literature review and personal experience, J Eur Acad Dermatol Venereol, 26, 942, 10.1111/j.1468-3083.2011.04427.x Weinstock, 1991, Nonmelanoma skin cancer mortality: a population-based study, Arch Dermatol, 127, 1194, 10.1001/archderm.1991.01680070094012 Spates, 2003, Metastatic basal cell carcinoma, Dermatol Surg, 29, 650 Pfeiffer, 1990, Systemic cytotoxic therapy of basal cell carcinoma: a review of the literature, Eur J Cancer Clin Oncol, 26, 73, 10.1016/0277-5379(90)90262-R Peck, 1988, Treatment and prevention of basal cell carcinoma with oral isotretinoin, J Am Acad Dermatol, 19, 176, 10.1016/S0190-9622(88)70162-0 Kalapurakal, 2012, Cetuximab in refractory skin cancer treatment, J Cancer, 3, 257 Von Hoff, 2009, Inhibition of the hedgehog pathway in advanced basal-cell carcinoma, N Engl J Med, 361, 1164, 10.1056/NEJMoa0905360 Sekulic, 2012, Efficacy and safety of vismodegib in advanced basal-cell carcinoma, N Engl J Med, 366, 2171, 10.1056/NEJMoa1113713 Jacobsen, 2016, Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies, JAMA Dermatol, 152, 816, 10.1001/jamadermatol.2016.0780 Wahid, 2016, Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas, Crit Rev Oncol Hematol, 98, 235, 10.1016/j.critrevonc.2015.11.006 Basset-Seguin, 2015, Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial, Lancet Oncol, 16, 729, 10.1016/S1470-2045(15)70198-1 Lear, 2018, Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study, J Eur Acad Dermatol Venereol, 32, 372, 10.1111/jdv.14542 Dummer, 2021, Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months, J Am Acad Dermatol, 84, 1162, 10.1016/j.jaad.2020.08.042 Dummer, 2020, Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study, Br J Dermatol, 182, 1369, 10.1111/bjd.18552 Dummer, 2020, Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion, J Eur Acad Dermatol Venereol, 34, 1944, 10.1111/jdv.16230 Dréno, 2017, Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial, Lancet Oncol, 18, 404, 10.1016/S1470-2045(17)30072-4 Kim, 2014, Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma, J Clin Oncol, 32, 745, 10.1200/JCO.2013.49.9525 Sekulic, 2015, Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC, J Am Acad Dermatol, 72, 1021, 10.1016/j.jaad.2015.03.021 Stratigos, 2021, Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial, Lancet Oncol, 22, 848, 10.1016/S1470-2045(21)00126-1